Atossa Genetics (ATOS) Reports Q2 Loss of $0.11

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.11), versus ($0.13) reported last year. Revenue for the quarter came in at $2.69 million versus the consensus estimate of $9.9 thousand.

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• TD Cowen Reiterates Hold Rating on Leidos Holdings (LDOS)
• Oil near $100, Fed rate fears and Iran tensions - what’s moving markets